Editas Medicine Inc
EDIT
$2.52-8.55%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$375.21M
EV/Sales
7.09
P/E ratio
N/A
FY2025 Revenue
$40.52M
EPS (TTM)
$-0.66
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-395.01%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported EDIT revenue for 2025-12-31 was $40.5M. Net income was -$160.1M. Revenue was up 25.4% from 2024-12-31 to 2025-12-31. EDIT currently screens at market cap $375.2M.
Use this EDIT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EDIT income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Editas Medicine Inc (EDIT) is a biotechnology company in the Healthcare sector.
Latest cached Editas Medicine Inc (EDIT) revenue for Dec 31, 2025 was $40.5M. Net income was -$160.1M. Statements: https://lician.com/financials/edit
Editas Medicine Inc (EDIT) market capitalization is $375.2M on the latest cached snapshot.
Editas Medicine Inc (EDIT) cached previous close $2.75; day range $2.52 – $2.73; volume 1,502,369. Session quote: https://lician.com/quote/edit
Editas Medicine Inc (EDIT) latest cached earnings event is "EDIT earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings